Tuberculosis (TB) and tumor, with similarities in immune response and pathogenesis, are diseases that are prone to produce autoimmune stress response to the host immune system. With a symbiotic relationship between the two, TB can facilitate the occurrence and development of tumors, while tumor causes TB reactivation. In this review, we systematically sorted out the incidence trends and influencing factors of TB and tumor, focusing on the potential pathogenesis of TB and tumor, to provide a pathway for the co-pathogenesis of TB comorbid with tumor (TCWT). Based on this, we summarized the latest progress in the diagnosis and treatment of TCWT, and provided ideas for further exploration of clinical trials and new drug development of TCWT.
[1]Kunming Med Univ, Sch Publ Hlth, Kunming, Peoples R China.
[2]China Natl Inst Sports Med A2 Pangmen, Ctr Sports Injury Prevent Treatment & Rehabil, Beijing, Peoples R China.
(8.0+极速模式)